Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis

Overview of attention for article published in Drug Design, Development and Therapy, September 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 4,030 followers.

RT @IronBiologyBot: Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferro…

Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis https://t.co/wSDZUTnjGg #IronBiology #BioIron #Iron

Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by In | DDDT - Dove Medical Press https://t.co/GL7mbHGzVJ